---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-114421"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:46:20.319038+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Longevity Health delisted from Nasdaq, now trades on OTC; merger with True Health planned

## Summary
- Received delisting notice from Nasdaq on Sept 10, 2025 for failure to cure Listing Rule 5550(b)(2) deficiency.
- Securities delisted at open Sept 12, 2025; common stock and warrants began trading on OTC Markets.
- Company states operations unaffected; will continue periodic SEC filings.
- Intends to pursue previously disclosed merger with True Health Inc. and relist on Nasdaq.

## SEC filing metadata
- accession: 0000950170-25-114421
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025114421/0000950170-25-114421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025114421/xage-20250910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-114421
- JSON: https://secwatch.observer/filing/0000950170-25-114421.json
- Plain text: https://secwatch.observer/filing/0000950170-25-114421.txt

## Key facts
- Listing & Compliance Notices
  Longevity Health Holdings, Inc. received a nasdaq delisting notice notice regarding other (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5550(b)(2)
  source text: September 10, 2025, Longevity Health Holdings, Inc., a Delaware corporation (the “Company”) received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company had not cured the previously reported deficiency with respect to Nasdaq Listing Rule 5550(b)(2) and as a result, the Panel determined to delist the Company’s securities from the Nasdaq Capital Market at the open of trading on September 12, 2025. The Company’s common stock and warrants began trading publicly on the over-the-counter markets operated by OTC Markets Group, Inc. (“OTC”) at the open of trading on S
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000095017025114421/0000950170-25-114421-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.